Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
The first few days after your weekly injection may carry the highest nausea risk
Tirzepatide Sometimes referred to as a dual-agonist because of its action beyond the GLP-1 receptor, tirzepatide is sold as Zepbound (approved for weight management) and Mounjaro (approved for diabetes)
Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular Events
Common adverse effects included weight loss, reduced appetite, and gastrointestinal symptoms such as nausea
For this purpose, as well as for further questions on the subject of personal data, you can contact us at any time at the address given in the imprint
US$ 28.09
US$ 29.23
US$ 24.55
US$ 23.37
US$ 22.78
US$ 23.17
US$ 26.17
US$ 24.17
